Redhill Capital is managing two RMB funds and one USD fund.
Has invested in more than 30 high-growth innovative companies

Portfolio

  • 灵犀云
  • 灵犀云

  • 道博医疗
  • 道博医疗

  • 乐橙云服
  • 乐橙云服

  • HAMESH
  • HAMESH

  • 睿渠
  • 睿渠

  • 信华生物
  • 信华生物

  • 英伟医疗
  • 英伟医疗

  • 善思微
  • 善思微

  • 谱洛美施
  • 谱洛美施

  • 深圳市赛诺思医疗科技有
  • 深圳市赛诺思医疗科技有限公司成立于2017年3月,由丹麓资本独家投资。公司位于深圳市坪山区国家级生物医药产业基地。公司的创始团队和技术顾问包含了国内外顶级心脏电生理专家,心脏外科专家,具有美国药监局和中国药监局医疗器械临床和注册经验的专家,以及心血管领域医疗器械资深研发人员,是一家专注于心脏电生理领域的新技术和产品研发的创新型科技公司。公司研发的经心外膜化学消融治疗房颤装置,可以显著降低目前手术成本,并降低手术操作要求,提高持续性房颤消融的手术成功率,让更多的房颤病人得到更有效的治疗。该技术为全球首创技术

  • 深圳韦拓生物科技有限公
  • 深圳韦拓生物科技有限公司(VitaVitro)是一家专注于人类辅助生殖领域的国家高新技术企业。公司成立于2015年,总部位于深圳,合作伙伴遍及全球,主营业务包括辅助生殖实验室用全套无菌试剂,管材及设备。产品获得美国FDA及CFDA认证,通过了欧盟权威机构ISO13485质量体系认证,远销欧洲,美洲及亚太地区并享有良好声誉。

  • 香港美亚特医
  • 香港美亚特医

  • 广州源博医药科技有限公
  • 源博医药科技一家人用和兽用生物制品研发企业,基于杆状病毒、昆虫细胞表达抗原技术平台和结构免疫辅助疫苗设计技术平台,研发涉及人用和兽用疫苗及兽用诊断制品等。

  • 广州源古纪科技有限公司
  • 源古纪成立于2019年,公司以呼吸感染赛道为核心,依托国家呼吸医学中心(广州呼吸健康研究院等)推进网络建设,打造以分子检测为主(包括但不限于mNGS、二代、 三代测序),包含检测、产品

  • 苏州新芽基因生物技术有
  • 新芽基因是一家利用碱基编辑技术开发基因治疗药物的公司,该技术在DMD治疗领域显示出明显的优势。新芽基因拥有自主知识产权的基因编辑技术(Targeted AID-mediated Mutagenesis

  • Fujian pilot Free Trad
  • Manteia is committed to deep learning, data technology and traditional algorithm research in the field of tumor radiotherapy. Headquartered in Xiamen, China, with a wholly-owned subsidiary in the United States, it is an enterprise of "double hundred talents" introduced by Xiamen municipal government and a strategic investment enterprise of Fosun Group and Danlu capital in the field of radiotherapy.

    The company has R & D teams in China and American design, with about 50 algorithms and engineers, including 40% doctors and 30% masters. The core R & D personnel have published more than 170 SCI literatures in the field of radiotherapy. It has 26 software copyrights, 2 international patents and 6 domestic patents.
    The company's main research fields are: medical imaging, biological dose, calculation and optimization engine and automatic control. It has completed many software products such as software system "automatic drawing and image workstation", "plan automatic evaluation and optimization system", "safety and information system" and "adaptive radiotherapy system", and has been successfully deployed and applied in hundreds of hospitals at home and abroad.

  • Chongqing mingyitang h
  • 1. Background of medical health group

    Wenkang group has been deeply engaged in the internet medical service and medical big health industry for many years. Its business covers online medical treatment, regional intelligent medical treatment, intelligent health management, pharmaceutical e-commerce, etc. the group has successively obtained heavyweight capital investments such as Yunfeng fund, CCB international and Lenovo holding group.

    2. A modern comprehensive secondary hospital with traditional Chinese medicine characteristics, with stable team and mature operation.

    Founded in October 2016, mingyitang hospital integrates medical diagnosis and treatment, health management, remote consultation and rehabilitation physiotherapy. It has more than 180 traditional Chinese medicine experts. In less than three years of establishment, the number of outpatients has increased by nearly 50% annually, and the average revenue growth rate in recent two years has exceeded 123%.
    3. The regional chain has expanded steadily to build a chain brand of traditional Chinese medicine industry in Sichuan and Chongqing.
    By the end of August 2019, the preliminary chain will be completed, covering 5 outpatient clinics with one hospital in Sichuan and Chongqing. In the next three years, about 30 chain stores will be built through self construction or M & A, so as to become a leading brand in the traditional Chinese medicine industry in Sichuan and Chongqing.

  • Shenzhen haisi'an Biot
  • Founded in 2016, hisan is committed to the in vitro diagnosis (IVD) industry's real-time detection (POCT) segment. It has a unique patented real-time detection technology, focusing on the diagnosis of autoimmune diseases and early detection of infectious

  • Heyuan Biotechnology (
  • Heyuan Biotechnology (Tianjin) Co., Ltd. is a biopharmaceutical enterprise focusing on the R & D of innovative immune cell therapy drugs. It is committed to building the whole industry chain business of R & D, production and sales of immune cell therapy drugs. Founded in June 2018, the company is headquartered in China Trade Center, Chaoyang District, Beijing, and has established an immune cell therapy drug transformation and production base in Tianjin Binhai high tech Zone. Relying on the preliminary technical achievements of domestic first-class hematology hospitals and hematology research institutes, the company speeds up the transformation of scientific research achievements of car-t and other cell therapy drugs.

    At present, the company's first new drug clinical trial application for immune cell therapy product cnct19 has been officially accepted by the State Drug Administration. The follow-up pipeline products will be continuously promoted to provide effective treatment methods for malignant blood tumors such as leukemia and lymphoma. At present, the company has 1300 square meters of R & D center in Beijing, 1400 square meters of GMP immune cell drug R & D, transformation and production facilities in Tianjin, and 7000 square meters of GMP immune cell drug production base is under construction.
    With an efficient R & D and transformation platform, the company will create safe, effective and accessible high-quality cell therapy products for Chinese patients through strict cell therapy product production and quality system!

  • Changzhou Zhishan Medi
  • Zhishan medical was founded in May 2017, initiated by Shanlan capital, Junlian capital and Softbank China capital, and jointly founded by top medical experts and senior medical device industry people in the United States, France and China. Danlu capital led the investment in pre-A. Zhishan medical is engaged in the R & D, production and sales of non-invasive weight loss medical devices. With the mission of "keeping the majority of obese people away from chronic diseases and improving the quality of life", Zhishan medical is committed to becoming a provider of high-quality and cost-effective non-invasive weight loss devices and a promoter of global non-invasive weight loss technology innovation.
    The company has established a large-scale production base in Changzhou, a R & D center in Shanghai Zhangjiang Science City, and liaison offices in the United States and France to select new technologies and promote global business and clinical cooperation. The first product developed by the company, intragastric balloon system, is the first in China and the leading technology in the world.

  • Hunan Kefu Medical Tec
  • Hunan Kefu Medical Technology Development Co., Ltd. (hereinafter referred to as the company), founded in 2009, has 16 subsidiaries and 61 branches. Now it has developed into a group enterprise integrating medical device R & D, manufacturing, sales and service.
    The company is committed to improving the quality of life of the people with more scientific, humanized and intelligent household medical products, and caring for more families with high-quality products. "Cofoe" trademark has been registered in the EU and has submitted registration applications to more than 50 countries around the world. At present, it mainly develops and produces more than 600 categories of products, such as 6864 medical consumables and dressings and 6826 physical therapy and rehabilitation equipment. After years of accumulation, the company has the ability of R & D, production, sales and service of intelligent medical products, and has more than 110 medical device licenses and 216 patents. At present, the company has more than 12000 kinds of products, complete varieties and wide coverage, covering medical devices for pregnant women, household medical devices for newborn children and medical devices for family elderly care, including six product categories: wheelchair, blood glucose meter, sphygmomanometer, oxygen generator, hearing aid and crutch walker, which has reached the industry leading market share of rehabilitation products.

    The company provides diversified products and services for 100000 pharmacies and more than 10 million families in China. Now it is one of the most comprehensive operators in China. Its products are exported to more than 20 countries and regions overseas, and there are storage centers in the United States, Britain, Australia and Russia. The company has set up two R & D centers in Hangzhou and Changsha, two factories in Changsha and Yueyang, Hunan Province, standardized experimental centers and first-class production equipment, and the implementation of ISO9001:2000 and ISO13485 quality systems, which provide a reliable guarantee for product R & D and production quality. The establishment of technology center and sales center has continuously improved the scientific research level and sales capacity, and provided a guarantee for the company to maintain its leading position in the industry.
    In the future, the company will further increase scientific research investment, produce more scientific, innovative, humanized and intelligent adaptive household medical device products, serve tens of millions of families through perfect online and offline channels, and is committed to building "Kefu" into a world-class household medical device brand trusted by consumers.

  • Shenzhen beirelaxed Te
  • Founded in 2000, beirelaxed is an enterprise integrating R & D, production and sales of intelligent portable massagers. Over the years, beieasily has focused on innovative R & D and created a series of portable hand imitation massage products such as head

  • Suzhou liangyihui Netw
  • Liangyihui is an authoritative anti-cancer academic platform, an officially designated cooperation platform of the Chinese society of Clinical Oncology, and a strategic partner of the China Women's foundation. It also maintains long-term and effective in-depth cooperation with many well-known hospitals and authoritative institutions at home and abroad. Liangyihui is committed to solving the situation of information asymmetry in the professional field. It is an efficient tool for oncologists. It will also become a popular science publicity for cancer patients and the public, and an all-round platform for cancer prevention and anti-cancer.

  • Beijing Zhiyuan huitu
  • Beijing Zhiyuan huitu Technology Co., Ltd. (Vistel) is committed to entering the global eye health market of US $200 billion a year through ophthalmic AI and ophthalmic intelligent devices. Vistel was founded by executives and scientists from former Intel, Bell Labs and other companies, and has a number of experts in the field of ophthalmology as medical consultants. Vistel's eyewisdom ® Eye AI solution can analyze and diagnose common blinding eye diseases efficiently, accurately and in real time. Vistel's ophthalmic intelligent hardware equipment is committed to creating innovative devices with high cost performance. Vistel's system is widely used in Ophthalmology, endocrinology and physical examination / optometry centers. In terms of R & D, Vistel has carried out a number of innovative research with Beijing Union Medical College Hospital, Beijing Tongren Hospital, the Third Hospital of Beijing Medical College and Henan Provincial eye hospital. In terms of application, Vistel has established strategic cooperative relations with ophthalmic equipment manufacturers and pharmaceutical companies at home and abroad. Vistel is a national high-tech enterprise, Zhongguancun high-tech enterprise and ZhongGuanCun "golden seed" enterprise. It has published 10 papers and applied for 20 patents at MICCAI and other top meetings.